Updated Jul 16, 2026
Namouni Fouad has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $324K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-17 | BPMC | Blueprint Medicines Corp | J — Other acquisition / disposition | 32.0K | — | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | D — Derivative transaction | 83.3K | — | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | A — Grant or award | 39.5K | — | |
| 2024-10-04 | BPMC | Blueprint Medicines Corp | S — Open-market sale | 3.6K | $89.32 | $324K |
Namouni Fouad is a corporate insider — currently tracked as Insider of Vor Biopharma Inc. (VOR). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($324K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Namouni Fouad profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.